Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population) By (Pediatrics, Adult) & Brands Analysis
Buy NowGlobal Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is the 8th report by Renub Research on Influenza Vaccine Market.
Get Free 10% Customization in This Report
Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period.
United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022.
This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market. All 30 Countries have been extensively studied from 2 major points, which has been further sub-divided into 2 more points:
1. Influenza Vaccine Market & Forecast (2011 – 2022)
a. Pediatrics Influenza Vaccine Market & Forecast
b. Adult Influenza Vaccine Market & Forecast
2. Influenza Vaccinated Population & Forecast (2011 – 2022)
a. Pediatrics Influenza Vaccinated Population & Forecast
b. Adult Influenza Vaccinated Population & Forecast
30 Countries Influenza Vaccine Market covered in the report are as follows
1. United States
2. Netherlands
3. Denmark
4. Estonia
5. Finland
6. Germany
7. France
8. Hungary
9. Iceland
10. Ireland
11. Italy
12. Latvia
13. Lithuania
14. Luxembourg
15. Malta
16. Norway
17. Poland
18. Portugal
19. Romania
20. Slovakia
21. Slovenia
22. Spain
23. Sweden
24. United Kingdom
25. China
26. India
27. Brazil
28. Japan
29. Australia
30. New Zealand
This report offers the best viewpoint on the leading five influenza vaccine brands
1. Vaxigrip/Fluzone
2. Fluarix/ Flulaval
3. FluMist/Fluenz
4. Afluria/Fluvax and Fluvirin/Flucelvax
5. Anflu
Scope of Study
• Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market.
• Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast.
• Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast.
• Influenza Vaccine Brand Sales and Forecast
This report is a combination of 6 reports
1. Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis
2. Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast
3. Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)
4. Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination
5. Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia (East Europe) By (Infant & Adult) Forecast
6. Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast
1 Executive Summary
2 Influenza – Introduction
2.1 Different Types of Influenza Viruses
2.1.1 Type A Flu Virus
2.1.2 Type B Flu Virus
2.1.3 Type C Flu Virus
2.1.4 Type D Flu Virus
2.2 An Influenza Pandemic
3 Structure of Influenza Virus
4 Notable Influenza Pandemics
5 Worldwide Influenza Vaccinated Population
5.1 Worldwide Seasonal Influenza Vaccinated Child Population
5.2 Worldwide Seasonal Influenza Vaccinated Adult Population
6 Worldwide Seasonal Influenza Vaccine Market
6.1 Worldwide - Seasonal Influenza Child Vaccine Market
6.2 Worldwide Seasonal Influenza Adult Vaccine Market
7 Worldwide Seasonal Influenza Vaccine Market Share Analysis
7.1 Worldwide Seasonal Influenza Vaccine Market Share
7.2 Worldwide Seasonal Influenza Child Vaccine Market Share
7.3 Worldwide Seasonal Influenza Adult Vaccine Market Share
8 United States
8.1 United States Seasonal Influenza Vaccinated Total Population
8.1.1 United States Seasonal Influenza Vaccinated Child Population
8.1.2 United States Seasonal Influenza Vaccinated Adult Population
8.2 United States Seasonal Influenza Vaccine Market
8.2.1 United States Seasonal Influenza Child Vaccine Market
8.2.2 United States Seasonal Influenza Adult Vaccine Market
9 Netherlands
9.1 Netherlands Seasonal Influenza Vaccinated Total Population
9.1.1 Netherlands Seasonal Influenza Vaccinated Child Population
9.1.2 Netherlands Seasonal Influenza Vaccinated Adult Population
9.2 Netherlands Seasonal Influenza Vaccine Market
9.2.1 Netherlands Seasonal Influenza Child Vaccine Market
9.2.2 Netherlands Seasonal Influenza Adult Vaccine Market
10 Denmark
10.1 Denmark Seasonal Influenza Vaccinated Total Population
10.1.1 Denmark Seasonal Influenza Vaccinated Child Population
10.1.2 Denmark Seasonal Influenza Vaccinated Adult Population
10.2 Denmark Seasonal Influenza Vaccine Market
10.2.1 Denmark Seasonal Influenza Child Vaccine Market
10.2.2 Denmark Seasonal Influenza Adult Vaccine Market
11 Estonia
11.1 Estonia Seasonal Influenza Vaccinated Total Population
11.1.1 Estonia Seasonal Influenza Vaccinated Child Population
11.1.2 Estonia Seasonal Influenza Vaccinated Adult Population
11.2 Estonia Seasonal Influenza Vaccine Market
11.2.1 Estonia Seasonal Influenza Child Vaccine Market
11.2.2 Estonia Seasonal Influenza Adult Vaccine Market
12 Finland
12.1 Finland Seasonal Influenza Vaccinated Total Population
12.1.1 Finland Seasonal Influenza Vaccinated Child Population
12.1.2 Finland Seasonal Influenza Vaccinated Adult Population
12.2 Finland Seasonal Influenza Vaccine Market
12.2.1 Finland Seasonal Influenza Child Vaccine Market
12.2.2 Finland Seasonal Influenza Adult Vaccine Market
13 Germany
13.1 Germany Seasonal Influenza Vaccinated Total Population
13.1.1 Germany Seasonal Influenza Vaccinated Child Population
13.1.2 Germany Seasonal Influenza Vaccinated Adult Population
13.2 Germany Seasonal Influenza Vaccine Market
13.2.1 Germany Seasonal Influenza Child Vaccine Market
13.2.2 Germany Seasonal Influenza Adult Vaccine Market
14 France
14.1 France Seasonal Influenza Vaccinated Total Population
14.1.1 France Seasonal Influenza Vaccinated Child Population
14.1.2 France Seasonal Influenza Vaccinated Adult Population
14.2 France Seasonal Influenza Vaccine Market Analysis
14.2.1 France Seasonal Influenza Child Vaccine Market
14.2.2 France Seasonal Influenza Adult Vaccine Market
15 Hungary
15.1 Hungary Seasonal Influenza Vaccinated Total Population
15.1.1 Hungary Seasonal Influenza Vaccinated Child Population
15.1.2 Hungary Seasonal Influenza Vaccinated Adult Population
15.2 Hungary Seasonal Influenza Vaccine Market
15.2.1 Hungary Seasonal Influenza Child Vaccine Market
15.2.2 Hungary Seasonal Influenza Adult Vaccine Market
16 Iceland
16.1 Iceland Seasonal Influenza Vaccinated Total Population
16.1.1 Iceland Seasonal Influenza Vaccinated Child Population
16.1.2 Iceland Seasonal Influenza Vaccinated Adult Population
16.2 Iceland Seasonal Influenza Vaccine Market
16.2.1 Iceland Seasonal Influenza Child Vaccine Market
16.2.2 Iceland Seasonal Influenza Adult Vaccine Market
17 Ireland
17.1 Ireland Seasonal Influenza Vaccinated Total Population
17.1.1 Ireland Seasonal Influenza Vaccinated Child Population
17.1.2 Ireland Seasonal Influenza Vaccinated Adult Population
17.2 Ireland Seasonal Influenza Vaccine Market
17.2.1 Ireland Seasonal Influenza Child Vaccine Market
17.2.2 Ireland Seasonal Influenza Adult Vaccine Market
18 Italy
18.1 Italy Seasonal Influenza Vaccinated Total Population
18.1.1 Italy Seasonal Influenza Vaccinated Child Population
18.1.2 Italy Seasonal Influenza Vaccinated Adult Population
18.2 Italy Seasonal Influenza Vaccine Market
18.2.1 Italy Seasonal Influenza Child Vaccine Market
18.2.2 Italy Seasonal Influenza Adult Vaccine Market
19 Latvia
19.1 Latvia Seasonal Influenza Vaccinated Total Population
19.1.1 Latvia Seasonal Influenza Vaccinated Child Population
19.1.2 Latvia Seasonal Influenza Vaccinated Adult Population
19.2 Latvia Seasonal Influenza Vaccine Market
19.2.1 Latvia Seasonal Influenza Child Vaccine Market
19.2.2 Latvia Seasonal Influenza Adult Vaccine Market
20 Lithuania
20.1 Lithuania Seasonal Influenza Vaccinated Total Population
20.1.1 Lithuania Seasonal Influenza Vaccinated Child Population
20.1.2 Lithuania Seasonal Influenza Vaccinated Adult Population
20.2 Lithuania Seasonal Influenza Vaccine Market
20.2.1 Lithuania Seasonal Influenza Child Vaccine Market
20.2.2 Lithuania Seasonal Influenza Adult Vaccine Market
21 Luxembourg
21.1 Luxembourg Seasonal Influenza Vaccinated Total Population
21.1.1 Luxembourg Seasonal Influenza Vaccinated Child Population
21.1.2 Luxembourg Seasonal Influenza Vaccinated Adult Population
21.2 Luxembourg Seasonal Influenza Vaccine Market
21.2.1 Luxembourg Seasonal Influenza Child Vaccine Market
21.2.2 Luxembourg Seasonal Influenza Adult Vaccine Market
22 Malta
22.1 Malta Seasonal Influenza Vaccinated Total Population
22.1.1 Malta Seasonal Influenza Vaccinated Child Population
22.1.2 Malta Seasonal Influenza Vaccinated Adult Population
22.2 Malta Seasonal Influenza Vaccine Market
22.2.1 Malta Seasonal Influenza Child Vaccine Market
22.2.2 Malta Seasonal Influenza Adult Vaccine Market
23 Norway
23.1 Norway Seasonal Influenza Vaccinated Total Population
23.1.1 Norway Seasonal Influenza Vaccinated Child Population
23.1.2 Norway Seasonal Influenza Vaccinated Adult Population
23.2 Norway Seasonal Influenza Vaccine Market
23.2.1 Norway Seasonal Influenza Child Vaccine Market
23.2.2 Norway Seasonal Influenza Adult Vaccine Market
24 Poland
24.1 Poland Seasonal Influenza Vaccinated Total Population
24.1.1 Poland Seasonal Influenza Vaccinated Child Population
24.1.2 Poland Seasonal Influenza Vaccinated Adult Population
24.2 Poland Seasonal Influenza Vaccine Market
24.2.1 Poland Seasonal Influenza Child Vaccine Market
24.2.2 Poland Seasonal Influenza Adult Vaccine Market
25 Portugal
25.1 Portugal Seasonal Influenza Vaccinated Total Population
25.1.1 Portugal Seasonal Influenza Vaccinated Child Population
25.1.2 Portugal Seasonal Influenza Vaccinated Adult Population
25.2 Portugal Seasonal Influenza Vaccine Market
25.2.1 Portugal Seasonal Influenza Child Vaccine Market
25.2.2 Portugal Seasonal Influenza Adult Vaccine Market
26 Romania
26.1 Romania Seasonal Influenza Vaccinated Total Population
26.1.1 Romania Seasonal Influenza Vaccinated Child Population
26.1.2 Romania Seasonal Influenza Vaccinated Adult Population
26.2 Romania Seasonal Influenza Vaccine Market
26.2.1 Romania Seasonal Influenza Child Vaccine Market
26.2.2 Romania Seasonal Influenza Adult Vaccine Market
27 Slovakia
27.1 Slovakia Seasonal Influenza Vaccinated Total Population
27.1.1 Slovakia Seasonal Influenza Vaccinated Child Population
27.1.2 Slovakia Seasonal Influenza Vaccinated Adult Population
27.2 Slovakia Seasonal Influenza Vaccine Market
27.2.1 Slovakia Seasonal Influenza Child Vaccine Market
27.2.2 Slovakia Seasonal Influenza Adult Vaccine Market
28 Slovenia
28.1 Slovenia Seasonal Influenza Vaccinated Total Population
28.1.1 Slovenia Seasonal Influenza Vaccinated Child Population
28.1.2 Slovenia Seasonal Influenza Vaccinated Adult Population
28.2 Slovenia Seasonal Influenza Vaccine Market
28.2.1 Slovenia Seasonal Influenza Child Vaccine Market
28.2.2 Slovenia Seasonal Influenza Adult Vaccine Market
29 Spain
29.1 Spain Seasonal Influenza Vaccinated Total Population
29.1.1 Spain Seasonal Influenza Vaccinated Child Population
29.1.2 Spain Seasonal Influenza Vaccinated Adult Population
29.2 Spain Seasonal Influenza Vaccine Market
29.2.1 Spain Seasonal Influenza Child Vaccine Market
29.2.2 Spain Seasonal Influenza Adult Vaccine Market
30 Sweden
30.1 Sweden Seasonal Influenza Vaccinated Total Population
30.1.1 Sweden Seasonal Influenza Vaccinated Child Population
30.1.2 Sweden Seasonal Influenza Vaccinated Adult Population
30.2 Sweden Seasonal Influenza Vaccine Market
30.2.1 Sweden Seasonal Influenza Child Vaccine Market
30.2.2 Sweden Seasonal Influenza Adult Vaccine Market
31 United Kingdom
31.1 United Kingdom Seasonal Influenza Vaccinated Total Population
31.1.1 United Kingdom Seasonal Influenza Vaccinated Child Population
31.1.2 United Kingdom Seasonal Influenza Vaccinated Adult Population
31.2 United Kingdom Seasonal Influenza Vaccine Market
31.2.1 United Kingdom Seasonal Influenza Child Vaccine Market
31.2.2 United Kingdom Seasonal Influenza Adult Vaccine Market
32 China
32.1 China Seasonal Influenza Vaccinated Total Population
32.1.1 China Seasonal Influenza Vaccinated Child Population
32.1.2 China Seasonal Influenza Vaccinated Adult Population
32.2 China Seasonal Influenza Vaccine Market
32.2.1 China Seasonal Influenza Child Vaccine Market
32.2.2 China Seasonal Influenza Adult Vaccine Market
33 India
33.1 India Seasonal Influenza Vaccinated Total Population
33.1.1 India Seasonal Influenza Vaccinated Child Population
33.1.2 India Seasonal Influenza Vaccinated Adult Population
33.2 India Seasonal Influenza Vaccine Market
33.2.1 India Seasonal Influenza Child Vaccine Market
33.2.2 India Seasonal Influenza Adult Vaccine Market
34 Brazil
34.1 Brazil Seasonal Influenza Vaccinated Total Population
34.1.1 Brazil Seasonal Influenza Vaccinated Child Population
34.1.2 Brazil Seasonal Influenza Vaccinated Adult Population
34.2 Brazil Seasonal Influenza Vaccine Market
34.2.1 Brazil Seasonal Influenza Child Vaccine Market
34.2.2 Brazil Seasonal Influenza Adult Vaccine Market
35 Japan
35.1 Japan Seasonal Influenza Vaccinated Total Population
35.1.1 Japan Seasonal Influenza Vaccinated Child Population
35.1.2 Japan Seasonal Influenza Vaccinated Adult Population
35.2 Japan Seasonal Influenza Vaccine Market
35.2.1 Japan Seasonal Influenza Child Vaccine Market
35.2.2 Japan Seasonal Influenza Adult Vaccine Market
36 Australia
36.1 Australia Seasonal Influenza Vaccinated Total Population
36.1.1 Australia Seasonal Influenza Vaccinated Child Population
36.1.2 Australia Seasonal Influenza Vaccinated Adult Population
36.2 Australia Seasonal Influenza Vaccine Market
36.2.1 Australia Seasonal Influenza Child Vaccine Market
36.2.2 Australia Seasonal Influenza Adult Vaccine Market
37 New Zealand
37.1 New Zealand Seasonal Influenza Vaccinated Total Population
37.1.1 New Zealand Seasonal Influenza Vaccinated Child Population
37.1.2 New Zealand Seasonal Influenza Vaccinated Adult Population
37.2 New Zealand Seasonal Influenza Vaccine Market
37.2.1 New Zealand Seasonal Influenza Child Vaccine Market
37.2.2 New Zealand Seasonal Influenza Adult Vaccine Market
38 Worldwide – Seasonal Influenza Vaccine Brand Sales and Forecast
38.1 Vaxigrip / Fluzone Vaccine Sales and Forecast
38.2 Fluarix / Flulaval Vaccine Sales and Forecast
38.3 FluMist/Fluenz Vaccine Sales and Forecast
38.4 Afluria / Fluvax and Fluvirin / Flucelvax Vaccine Sales and Forecast
38.5 Anflu Vaccine Sales and Forecast
39 Seasonal Influenza Vaccine – Growth Drivers
39.1 Growing Awareness on Seasonal Influenza Vaccination
39.2 Vaccine Companies Plan to Augment Flu Vaccine Production
39.3 Increased Engagement by the Governments
40 Seasonal Influenza Vaccine – Challenges
40.1 Regulatory Issues with Novel Influenza Vaccines
40.2 Lack of Healthcare Infrastructure
40.3 Limited Reimbursement and Access to the Vaccines
40.4 China Tightens Rules on Vaccine Distribution
List of Figures
Figure 3‑1: Structure of Influenza Virus
Figure 5‑1: Worldwide - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 5‑2: Worldwide – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 5‑3: Worldwide - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5‑4: Worldwide – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5‑5: Worldwide - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5‑6: Worldwide – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6‑1: Worldwide - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6‑2: Worldwide – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6‑3: Worldwide - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6‑4: Worldwide – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6‑5: Worldwide - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6‑6: Worldwide – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8‑1: United States – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016
Figure 8‑2: United States – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 – 2022
Figure 8‑3: United States - Seasonal Influenza Vaccinated Child Population (Thousands), 2011 – 2016
Figure 8‑4: United States – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022
Figure 8‑5: United States - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016
Figure 8‑6: United States – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022
Figure 8‑7: United States - Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 8‑8: United States - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 8‑9: United States - Seasonal Influenza Children Vaccine Market (Million US$), 2011 – 2016
Figure 8‑10: United States - Seasonal Influenza Child Vaccine Market (Million US$), 2017 – 2022
Figure 8‑11: United States - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016
Figure 8‑12: United States - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 9‑1: Netherlands - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 9‑2: Netherlands – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 9‑3: Netherlands - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 9‑4: Netherlands – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 9‑5: Netherlands - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 9‑6: Netherlands – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 9‑7: Netherlands - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 9‑8: Netherlands – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 9‑9: Netherlands - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 9‑10: Netherlands – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 9‑11: Netherlands - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 9‑12: Netherlands – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 10‑1: Denmark - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 10‑2: Denmark – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 10‑3: Denmark - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 10‑4: Denmark – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 10‑5: Denmark - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 10‑6: Denmark – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 10‑7: Denmark - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 10‑8: Denmark – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 10‑9: Denmark - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 10‑10: Denmark – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 10‑11: Denmark - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 10‑12: Denmark – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 11‑1: Estonia – Seasonal Influenza Vaccinated Population (Thousand), 2011 – 2016
Figure 11‑2: Estonia –Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 – 2022
Figure 11‑3: Estonia- Seasonal Influenza Vaccinated Child Population (Thousand), 2011 – 2016
Figure 11‑4: Estonia- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 11‑5: Estonia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 11‑6: Estonia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 11‑7: Estonia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 11‑8: Estonia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 11‑9: Estonia - Seasonal Influenza Children Vaccine Market (Thousand US$), 2011 – 2016
Figure 11‑10: Estonia - Forecast for Seasonal Influenza Children Vaccine Market (Thousand US$), 2017 – 2022
Figure 11‑11: Estonia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 11‑12: Estonia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 12‑1: Finland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 12‑2: Finland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 12‑3: Finland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 12‑4: Finland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 12‑5: Finland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 12‑6: Finland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 12‑7: Finland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 12‑8: Finland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 12‑9: Finland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 12‑10: Finland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 12‑11: Finland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 12‑12: Finland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 13‑1: Germany – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 13‑2: Germany - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 13‑3: Germany – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 13‑4: Germany - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 13‑5: Germany – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 13‑6: Germany - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 13‑7: Germany – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 13‑8: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 13‑9: Germany – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 13‑10: Germany - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 13‑11: Germany- Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 13‑12: Germany- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 14‑1: France – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 14‑2: France - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 14‑3: France - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 14‑4: France- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 14‑5: France - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 14‑6: France - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 14‑7: France - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 14‑8: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 14‑9: France - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 14‑10: France - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 14‑11: France - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 14‑12: France - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 15‑1: Hungary - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 15‑2: Hungary – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 15‑3: Hungary - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 15‑4: Hungary – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 15‑5: Hungary – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 15‑6: Hungary- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 15‑7: Hungary – Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 15‑8: Hungary – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 15‑9: Hungary - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 15‑10: Hungary – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 15‑11: Hungary – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016
Figure 15‑12: Hungary - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022
Figure 16‑1: Iceland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 16‑2: Iceland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 16‑3: Iceland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 16‑4: Iceland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 16‑5: Iceland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 16‑6: Iceland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022
Figure 16‑7: Iceland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 16‑8: Iceland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 16‑9: Iceland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 16‑10: Iceland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 16‑11: Iceland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 16‑12: Iceland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 17‑1: Ireland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 17‑2: Ireland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 17‑3: Ireland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 17‑4: Ireland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 17‑5: Ireland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 17‑6: Ireland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 17‑7: Ireland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 17‑8: Ireland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 17‑9: Ireland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 17‑10: Ireland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 17‑11: Ireland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016
Figure 17‑12: Ireland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022
Figure 18‑1: Italy - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 18‑2: Italy - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 18‑3: Italy - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 18‑4: Italy - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 18‑5: Italy - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 18‑6: Italy - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 18‑7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 18‑8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 18‑9: Italy - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 18‑10: Italy - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 18‑11: Italy - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 18‑12: Italy- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 19‑1: Latvia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 19‑2: Latvia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 19‑3: Latvia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 19‑4: Latvia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 19‑5: Latvia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016
Figure 19‑6: Latvia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022
Figure 19‑7: Latvia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 19‑8: Latvia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 19‑9: Latvia- Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 19‑10: Latvia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 – 2022
Figure 20‑1: Lithuania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 20‑2: Lithuania - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 20‑3: Lithuania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 20‑4: Lithuania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 20‑5: Lithuania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 20‑6: Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 20‑7: Lithuania – Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 20‑8: Lithuania – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 20‑9: Lithuania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 20‑10: Lithuania – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 20‑11: Lithuania – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 20‑12: Lithuania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 21‑1: Luxembourg - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 21‑2: Luxembourg – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 21‑3: Luxembourg - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 21‑4: Luxembourg – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 21‑5: Luxembourg - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 21‑6: Luxembourg – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 21‑7: Luxembourg - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 21‑8: Luxembourg – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 – 2022
Figure 21‑9: Luxembourg - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 21‑10: Luxembourg – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 21‑11: Luxembourg - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 -2016
Figure 21‑12: Luxembourg – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 -2022
Figure 22‑1: Malta - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 22‑2: Malta – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 22‑3: Malta – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 22‑4: Malta – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 22‑5: Malta – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 22‑6: Malta – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 22‑7: Malta - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 22‑8: Malta – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 22‑9: Malta – Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 22‑10: Malta – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 22‑11: Malta - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 22‑12: Malta – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 23‑1: Norway - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 23‑2: Norway – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 23‑3: Norway - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 – 2016
Figure 23‑4: Norway – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022
Figure 23‑5: Norway - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 23‑6: Norway – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 23‑7: Norway - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 23‑8: Norway – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 23‑9: Norway - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 23‑10: Norway – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 23‑11: Norway - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 23‑12: Norway – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 24‑1: Poland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016
Figure 24‑2: Poland- Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 24‑3: Poland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 24‑4: Poland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 24‑5: Poland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 24‑6: Poland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 24‑7: Poland - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 24‑8: Poland - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 24‑9: Poland - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 24‑10: Poland - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 24‑11: Poland - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 24‑12: Poland - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017- 2022
Figure 25‑1: Portugal - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 25‑2: Portugal - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 25‑3: Portugal - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 25‑4: Portugal - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 25‑5: Portugal - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 25‑6: Portugal - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 25‑7: Portugal - Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 25‑8: Portugal - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 25‑9: Portugal - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 25‑10: Portugal - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 25‑11: Portugal - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 25‑12: Portugal - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 26‑1: Romania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 26‑2: Romania – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 26‑3: Romania – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 26‑4: Romania – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 26‑5: Romania – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 – 2016
Figure 26‑6: Romania – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 – 2022
Figure 26‑7: Romania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 26‑8: Romania – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 26‑9: Romania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 26‑10: Romania – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 26‑11: Romania – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 26‑12: Romania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 27‑1: Slovakia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 27‑2: Slovakia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 27‑3: Slovakia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 27‑4: Slovakia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 27‑5: Slovakia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 27‑6: Slovakia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 27‑7: Slovakia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 27‑8: Slovakia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 27‑9: Slovakia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 27‑10: Slovakia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 27‑11: Slovakia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 27‑12: Slovakia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 28‑1: Slovenia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 28‑2: Slovenia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 28‑3: Slovenia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 28‑4: Slovenia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 28‑5: Slovenia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 28‑6: Slovenia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 28‑7: Slovenia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 28‑8: Slovenia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 28‑9: Slovenia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 – 2016
Figure 28‑10: Slovenia - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 – 2022
Figure 28‑11: Slovenia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 28‑12: Slovenia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 29‑1: Spain – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 29‑2: Spain – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 29‑3: Spain – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 29‑4: Spain – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 29‑5: Spain - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 29‑6: Spain – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 29‑7: Spain - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 29‑8: Spain – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 29‑9: Spain –Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 29‑10: Spain – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 29‑11: Spain - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 29‑12: Spain – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 30‑1: Sweden - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 30‑2: Sweden – Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 30‑3: Sweden - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 30‑4: Sweden – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 30‑5: Sweden - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 30‑6: Sweden – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 30‑7: Sweden - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 30‑8: Sweden – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 30‑9: Sweden - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 30‑10: Sweden – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 30‑11: Sweden - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 30‑12: Sweden – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 31‑1: United Kingdom - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 31‑2: United Kingdom – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 31‑3: United Kingdom - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 31‑4: United Kingdom – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 31‑5: United Kingdom - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 31‑6: United Kingdom – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 31‑7: List of Seasonal Influenza Vaccines for the 2016/17 Influenza Season
Figure 31‑8: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 31‑9: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 31‑10: United Kingdom - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 31‑11: United Kingdom – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 31‑12: United Kingdom - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 31‑13: United Kingdom – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 32‑1: China - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 32‑2: China - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 32‑3: China - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 32‑4: China - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 32‑5: China - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 32‑6: China- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017- 2022
Figure 32‑7: China- Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 32‑8: China - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 32‑9: China - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 32‑10: China - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 32‑11: China - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016
Figure 32‑12: China - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 33‑1: India - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 33‑2: India - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 33‑3: India - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 33‑4: India- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 33‑5: India - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 33‑6: India - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 33‑7: India – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 33‑8: India - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 33‑9: India - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 33‑10: India - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 33‑11: India - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 33‑12: India - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 34‑1: Brazil - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 34‑2: Brazil – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 – 2022
Figure 34‑3: Brazil - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 34‑4: Brazil – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 34‑5: Brazil - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 34‑6: Brazil – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 34‑7: Brazil - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 34‑8: Brazil – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 34‑9: Brazil - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 34‑10: Brazil – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 34‑11: Brazil - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 34‑12: Brazil – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 35‑1: Japan - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 35‑2: Japan – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 35‑3: Japan - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 35‑4: Japan – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 35‑5: Japan - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 35‑6: Japan – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 35‑7: Japan - Seasonal Influenza Vaccine Market Analysis (Million US$), 2011 - 2016
Figure 35‑8: Japan – Forecast for Seasonal Influenza Vaccine Market Analysis (Million US$), 2017 - 2022
Figure 35‑9: Japan - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 35‑10: Japan – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 35‑11: Japan - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 35‑12: Japan – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 36‑1: Australia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 36‑2: Australia – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 36‑3: Australia – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 36‑4: Australia – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 36‑5: Australia – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 36‑6: Australia – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 36‑7: Registered Six Vaccines List
Figure 36‑8: Australia – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 36‑9: Australia – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 36‑10: Australia – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 36‑11: Australia – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 36‑12: Australia – Seasonal Influenza Adult Vaccine Market (Million US$), 2011 – 2016
Figure 36‑13: Australia – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 37‑1: The Difference between Influenza and a Common Cold
Figure 37‑2: New Zealand – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 37‑3: New Zealand – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 37‑4: New Zealand - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 37‑5: New Zealand – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 – 2022
Figure 37‑6: New Zealand - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 37‑7: New Zealand – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 37‑8: New Zealand - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 37‑9: New Zealand – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 37‑10: New Zealand - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 37‑11: New Zealand – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 37‑12: New Zealand – Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 37‑13: New Zealand – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 38‑1: Worldwide – Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑2: Worldwide – Forecast for Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2017– 2022
Figure 38‑3: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑4: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2017– 2022
Figure 38‑5: Worldwide – Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 38‑7: Worldwide – Afluria/Fluvax and Fluvirin/Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑8: Worldwide – Afluria/Fluvax and Fluvirin/Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑9: Worldwide – Anflu Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 38‑10: Worldwide – Forecast for Anflu Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 39‑1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015
Figure 40‑1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019
List of Tables
Table 4‑1: Notable Influenza Pandemics
Table 7‑1: Worldwide - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Table 7‑2: Worldwide – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Table 7‑3: Worldwide - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Table 7‑4: Worldwide – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Table 7‑5: Worldwide - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Table 7‑6: Worldwide – Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com